本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cullinan Therapeutics

20.54
+0.14000.69%
盤後20.30-0.2357-1.15%19:30 EDT
成交量:106.07萬
成交額:2,152.81萬
市值:13.22億
市盈率:-5.92
高:20.71
開:20.38
低:19.64
收:20.40
52周最高:23.19
52周最低:5.68
股本:6,435.47萬
流通股本:4,808.28萬
量比:0.96
換手率:2.21%
股息:- -
股息率:- -
每股收益(TTM):-3.4680
每股收益(LYR):-3.7236
淨資產收益率:-50.30%
總資產收益率:-31.36%
市淨率:4.11
市盈率(LYR):-5.52

資料載入中...

2026/09/14

重要事件披露

Form 8-K - Current report
2026/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/16

重要事件披露

Form 8-K - Current report
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/08

重要事件披露

Form 8-K - Current report
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/10

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]